Evidence map›Paper›PMID 35264045›Full record

ArticleThe Journal of international medical research2022

Descriptive epidemiology of soft tissue and bone sarcomas in Lebanon.

Maroun Bou Zerdan, Paul Meouchy, Nour Abdul Halim, Said Saghieh, Eman Sbaity, Rachid Haidar, Jaber Abbas, Amir Ibrahim, Mohamad Khalifeh, Hazem I Assi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maroun Bou ZerdanDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.
Paul MeouchyDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.
Nour Abdul HalimDepartment of Pediatrics, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.
Said SaghiehDepartment of Surgery, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.
Eman SbaityDepartment of Surgery, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.
Rachid HaidarDepartment of Surgery, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.
Jaber AbbasDepartment of Surgery, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.
Amir IbrahimDepartment of Surgery, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.
Mohamad KhalifehDepartment of Surgery, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.
Hazem I AssiDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, 66984American University of Beirut Medical Center, American University of Beirut Medical Center, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-8483-0938

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMost epidemiologic studies on soft tissue sarcomas (STS) and bone sarcomas (BS) are performed in western countries, with few in the Middle East and North Africa region. We describe the epidemiology of sarcomas in Lebanon using the medical records database at the American University of Beirut Medical Center (AUBMC).

methodsThis single-center retrospective cohort study included patients with sarcomas registered in the database between 2015 and 2019. Their charts were reviewed for baseline characteristics, tumor biology and location, treatment modalities, recurrence, metastasis, and death.

resultsThe cohort included 234 patients with STS and 99 patients with BS. Most tumors were <10 cm in size. The most common subtypes were liposarcoma for STS and osteosarcoma for BS. The most common location of STS was the thigh. The most frequent sites of STS metastasis were the lungs. Histological subtype, smoking status, and tumor size and grade were significant for progression-free survival (PFS) in patients with STS. By multivariable analysis, smoking was significantly associated with poorer PFS in STS. For BS, only tumor grade was significant for PFS.

conclusionThe epidemiology of sarcomas at AUBMC is similar to that previously reported. Smoking history was associated with poorer survival in patients with STS.

Indexed as

Bone NeoplasmsOsteosarcomaSarcomaHumansLebanonRetrospective Studiesangiosarcomadermatofibrosarcomaleiomyosarcomaliposarcomamalignant fibrous histiocytomarhabdomyosarcomaSoft tissue sarcoma

Identifiers

PMID35264045
PMCPMC8918978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.